These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 20146818)
1. The tuberculosis challenge in a rural South African HIV programme. Houlihan CF; Mutevedzi PC; Lessells RJ; Cooke GS; Tanser FC; Newell ML BMC Infect Dis; 2010 Feb; 10():23. PubMed ID: 20146818 [TBL] [Abstract][Full Text] [Related]
2. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies. Fenner L; Atkinson A; Boulle A; Fox MP; Prozesky H; Zürcher K; Ballif M; Furrer H; Zwahlen M; Davies MA; Egger M; J Int AIDS Soc; 2017 Jun; 20(1):21327. PubMed ID: 28691438 [TBL] [Abstract][Full Text] [Related]
3. High rates of tuberculosis in patients accessing HAART in rural South Africa. Naidoo K; Karim QA; Bhushan A; Naidoo K; Yende-Zuma N; McHunu PK; Frohlich J; Karim F; Upfold M; Kocheleff P; Abdool Karim SS J Acquir Immune Defic Syndr; 2014 Apr; 65(4):438-46. PubMed ID: 24256629 [TBL] [Abstract][Full Text] [Related]
4. Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa. Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD PLoS One; 2013; 8(2):e55824. PubMed ID: 23418463 [TBL] [Abstract][Full Text] [Related]
5. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. Lawn SD; Myer L; Bekker LG; Wood R AIDS; 2006 Aug; 20(12):1605-12. PubMed ID: 16868441 [TBL] [Abstract][Full Text] [Related]
6. Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa. Bock P; Jennings K; Vermaak R; Cox H; Meintjes G; Fatti G; Kruger J; De Azevedo V; Maschilla L; Louis F; Gunst C; Grobbelaar N; Dunbar R; Limbada M; Floyd S; Grimwood A; Ayles H; Hayes R; Fidler S; Beyers N J Acquir Immune Defic Syndr; 2018 Jan; 77(1):93-101. PubMed ID: 29016524 [TBL] [Abstract][Full Text] [Related]
7. Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India. Dravid A; Natarajan K; Medisetty M; Gawali R; Mahajan U; Kulkarni M; Saraf C; Ghanekar C; Kore S; Rathod N; Dravid M BMC Infect Dis; 2019 Aug; 19(1):714. PubMed ID: 31409289 [TBL] [Abstract][Full Text] [Related]
8. Temporal association between incident tuberculosis and poor virological outcomes in a South African antiretroviral treatment service. Gupta-Wright A; Wood R; Bekker LG; Lawn SD J Acquir Immune Defic Syndr; 2013 Nov; 64(3):261-70. PubMed ID: 23846570 [TBL] [Abstract][Full Text] [Related]
9. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. Lawn SD; Myer L; Edwards D; Bekker LG; Wood R AIDS; 2009 Aug; 23(13):1717-25. PubMed ID: 19461502 [TBL] [Abstract][Full Text] [Related]
10. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. Moore D; Liechty C; Ekwaru P; Were W; Mwima G; Solberg P; Rutherford G; Mermin J AIDS; 2007 Mar; 21(6):713-9. PubMed ID: 17413692 [TBL] [Abstract][Full Text] [Related]
11. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD PLoS One; 2012; 7(3):e34156. PubMed ID: 22479548 [TBL] [Abstract][Full Text] [Related]
12. Impact of ART on TB case fatality stratified by CD4 count for HIV-positive TB patients in Cape Town, South Africa (2009-2011). Kaplan R; Caldwell J; Middelkoop K; Bekker LG; Wood R J Acquir Immune Defic Syndr; 2014 Aug; 66(5):487-94. PubMed ID: 24820105 [TBL] [Abstract][Full Text] [Related]
13. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies. Van Rie A; Westreich D; Sanne I J Acquir Immune Defic Syndr; 2011 Apr; 56(4):349-55. PubMed ID: 20926954 [TBL] [Abstract][Full Text] [Related]
14. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. Lawn SD; Badri M; Wood R AIDS; 2005 Dec; 19(18):2109-16. PubMed ID: 16284460 [TBL] [Abstract][Full Text] [Related]
15. High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa. Msomi N; Naidoo K; Yende-Zuma N; Padayatchi N; Govender K; Singh JA; Abdool-Karim S; Abdool-Karim Q; Mlisana K BMC Infect Dis; 2020 Nov; 20(1):847. PubMed ID: 33198649 [TBL] [Abstract][Full Text] [Related]
16. Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy. Lawn SD; Kranzer K; Edwards DJ; McNally M; Bekker LG; Wood R AIDS; 2010 Jun; 24(9):1323-8. PubMed ID: 20386425 [TBL] [Abstract][Full Text] [Related]
17. HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort. Martinson NA; Moultrie H; van Niekerk R; Barry G; Coovadia A; Cotton M; Violari A; Gray GE; Chaisson RE; McIntyre JA; Meyers T Int J Tuberc Lung Dis; 2009 Jul; 13(7):862-7. PubMed ID: 19555536 [TBL] [Abstract][Full Text] [Related]
18. Tuberculosis prevalence, incidence and prevention in a south african cohort of children living with HIV. Anyalechi GE; Bain R; Kindra G; Mogashoa M; Sogaula N; Mutiti A; Arpadi S; Rivadeneira E; Abrams EJ; Teasdale CA J Trop Pediatr; 2022 Oct; 68(6):. PubMed ID: 36269203 [TBL] [Abstract][Full Text] [Related]
19. Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa. Kerkhoff AD; Wood R; Cobelens FG; Gupta-Wright A; Bekker LG; Lawn SD BMC Infect Dis; 2014 Dec; 14():3860. PubMed ID: 25528467 [TBL] [Abstract][Full Text] [Related]
20. Factors Associated With and Characteristic of HIV/Tuberculosis Co-Infection: A Retrospective Analysis of SECOND-LINE Clinical Trial Participants. Henry RT; Jiamsakul A; Law M; Losso M; Kamarulzaman A; Phanuphak P; Kumarasamy N; Foulkes S; Mohapi L; Nwizu C; Wood R; Kelleher A; Polizzotto M; J Acquir Immune Defic Syndr; 2021 May; 87(1):720-729. PubMed ID: 33399309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]